LBP and metabolic disease: The “weight loss” group also showed decreased levels of APOE, C5, CRP, LBP, NEGR1, and PRSS3, which have all been positively associated with obesity, inflammation, and metabolic disorders (Fig. 3B to G) (22, –, 26).